Overview

Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
Although prior dose-finding studies have investigated the optimal bolus dose of oxytocin to initiate adequate uterine tone, it is unclear what oxytocin infusion regimen is required to maintain adequate uterine tone after delivery. The study investigators aim to compare two different infusion rates of oxytocin to assess the optimal infusion regimen for reducing blood loss in women undergoing elective Cesarean delivery.
Phase:
Phase 3
Details
Lead Sponsor:
Stanford University
Treatments:
Oxytocin